← Leaderboards
Roderick O'Sullivan
University Of Pittsburgh At Pittsburgh
$5,003,277
Attributed
$5,003,277
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $831.7K · FY2016–25$1M$750K$500K$250K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,003,277 · 2
By mechanism
R01$5,003,277 · 2
Top collaborators
No co-investigators on record.
Most similar at University Of Pittsburgh At Pittsburgh
Same institution · by research overlap
- Patricia Lynn Opresko$15,295,285
- Cynthia St. Hilaire$4,566,908
- Aatur Dilip Singhi$4,515,533
- Jeffrey D Hildebrand$2,253,626
- Anne Wondisford$106,984
Others in their field
Top investigators on “Detection”
- David Divins · Consortium For Ocean Leadership, Inc$609,772,544
- Francis L Halzen · University Of Wisconsin-Madison$243,423,219
- Robert B Gagosian · Consortium For Ocean Leadership, Inc$232,495,072
- Richard A Gibbs · Baylor College Of Medicine$209,716,260
- Richard K. Wilson · Washington University$206,265,868
- Craig B Thompson · Sloan-Kettering Inst Can Research$156,512,301
Research focus
DetectionTelomere PathwayMolecularTelomere MaintenanceTelomereStructureMaintenanceMalignant NeoplasmsMutationRegulationResponseRepairedAffectDna DamageChromatinInnovationCellsBypassCancer CellChromatin ModelingChromosomesProteomicsPublic Health RelevanceAtrx Gene
Grant awards (13)
Co-Regulation of Alternative Lengthening of Telomeres and Chromatin Dynamics in ATRX-DAXX deficient cancer cells$463,559
R01 · FY2025 · CA · contact PI
Inhibition of the ALT pathway by interfering with Poly-ADP-Ribose metabolism$368,160
R01 · FY2025 · CA · contact PI
Co-Regulation of Alternative Lengthening of Telomeres and Chromatin Dynamics in ATRX-DAXX deficient cancer cells$440,381
R01 · FY2024 · CA · contact PI
Inhibition of the ALT pathway by interfering with Poly-ADP-Ribose metabolism$349,752
R01 · FY2024 · CA · contact PI
Co-Regulation of Alternative Lengthening of Telomeres and Chromatin Dynamics in ATRX-DAXX deficient cancer cells$447,821
R01 · FY2023 · CA · contact PI
Inhibition of the ALT pathway by interfering with Poly-ADP-Ribose metabolism$360,797
R01 · FY2023 · CA · contact PI
Co-Regulation of Alternative Lengthening of Telomeres and Chromatin Dynamics in ATRX-DAXX deficient cancer cells$456,960
R01 · FY2022 · CA · contact PI
Inhibition of the ALT pathway by interfering with Poly-ADP-Ribose metabolism$368,160
R01 · FY2022 · CA · contact PI
Inhibition of the ALT pathway by interfering with Poly-ADP-Ribose metabolism$349,004
R01 · FY2020 · CA · contact PI
Inhibition of the ALT pathway by interfering with Poly-ADP-Ribose metabolism$338,612
R01 · FY2019 · CA · contact PI
Inhibition of the ALT pathway by interfering with Poly-ADP-Ribose metabolism$349,164
R01 · FY2018 · CA · contact PI
Inhibition of the ALT pathway by interfering with Poly-ADP-Ribose metabolism$349,240
R01 · FY2017 · CA · contact PI
Inhibition of the ALT pathway by interfering with Poly-ADP-Ribose metabolism$361,667
R01 · FY2016 · CA · contact PI